Annual report
Page 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31 , 2021 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number : 001-12537 NEXTGEN HEALTHCARE , INC . ( Exact name of registrant as specified in its charter ) California ( State or other jurisdiction of incorporation or organization ) 3525 Piedmont Rd . , NE Building 6 , Suite 700 Atlanta , GA ( Address of principal executive offices ) * 95-2888568 Title of each class Common Stock , $ 0.01 Par Value ( IRS Employer Identification No. ) ( 404 ) 467-1500 ( Registrant's telephone number , including area code ) Securities registered pursuant to Section 12 ( b ) of the Act : Trading Symbol NXGN Securities registered pursuant to Section 12 ( g ) of the Act : None Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes No Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No 30305 ( Zip Code ) Name of each exchange on which registered NASDAQ Global Select Market Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( § 232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit ) . Yes No Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , smaller reporting company , or an emerging growth company . See the definitions of " large accelerated filer , " " accelerated filer , " and " smaller reporting company , " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . Large accelerated filer Accelerated filer Non - accelerated filer Smaller reporting company Emerging growth company If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Act ) . Yes No The aggregate market value of the voting stock held by non - affiliates of the Registrant as of September 30 , 2020 : $ 704,935,000 ( based on the closing sales price of the Registrant's common stock as reported on the NASDAQ Global Select Market on that date of $ 12.74 per share ) * The Registrant has no non - voting common equity . The number of outstanding shares of the Registrant's common stock as of May 24 , 2021 was 67,031,182 shares . For purposes of this Annual Report on Form 10 - K , in addition to those shareholders which fall within the definition of " affiliates " under Rule 405 of the Securities Act of 1933 , as amended , holders of ten percent or more of the Registrant's common stock are deemed to be affiliates for purposes of this Report . DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant's definitive proxy statement related to the 2021 Annual Shareholders ' Meeting to be filed with the Securities and Exchange Commission within 120 days of the registrant's fiscal year ended March 31 , 2021 are incorporated herein by reference in Part III of this Annual Report on Form 10 - K where indicated .